---
category: news
title: "FDA Grants Breakthrough Device Designation To Tempus' HLA-LOH Companion Diagnostic Test"
excerpt: "Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its HLA-L"
publishedDateTime: 2023-08-15T13:30:00Z
originalUrl: "https://www.benzinga.com/pressreleases/23/08/b33858918/fda-grants-breakthrough-device-designation-to-tempus-hla-loh-companion-diagnostic-test"
webUrl: "https://www.benzinga.com/pressreleases/23/08/b33858918/fda-grants-breakthrough-device-designation-to-tempus-hla-loh-companion-diagnostic-test"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Benzinga.com
  domain: benzinga.com

topics:
  - AI in Healthcare
  - AI

secured: "5YQCloNwnjHjyWudjsePzGzpCg17g+70pE9UF6iysHR2rmTBmgfTvVhnIcy/rotOdfHLkFM9CV5btHnntrrQxney7kWCrxOTeTxIfsu44XQtwFJQqQI6disfjjZ1nClHyDzwxTYgXe17QshumYLyPiGonAUnEUpfrntfAPgu7psd7bNyi40BME1emXyi/vzTatRjtteNA5QPTTRLkcwNg7Huvq3TmyY3PFx0nh666q7Wt5BlOmpsEWOE+cM+ancuLzAceohy0hRRWMDiqFXamyqtSORpagGdbgodCbD++QCwDEymecQwx0DzkiI1m5E24Tm/qgzMLxZS0BtJGlCBI3yPRgNm1YVl78KW27uBivk=;0oK2K7028U3cTNttRDLtAA=="
---

